Quent Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-74
| Closed | -$8.18K | – | 902 |
|
|
2025
Q1 | $8.18K | Hold |
74
| – | – | ﹤0.01% | 939 |
|
|
2024
Q4 | $10.1K | Sell |
74
-84
| -53% | -$11.5K | ﹤0.01% | 932 |
|
|
2024
Q3 | $18.2K | Hold |
158
| – | – | ﹤0.01% | 902 |
|
|
2024
Q2 | $21.8K | Hold |
158
| – | – | ﹤0.01% | 821 |
|
|
2024
Q1 | $21.8K | Buy |
158
+117
| +285% | +$16.1K | ﹤0.01% | 857 |
|
|
2023
Q4 | $5.4K | Buy |
41
+32
| +356% | +$4.22K | ﹤0.01% | 1059 |
|
|
2023
Q3 | $1.01K | Hold |
9
| – | – | ﹤0.01% | 1240 |
|
|
2023
Q2 | $849 | Hold |
9
| – | – | ﹤0.01% | 1251 |
|
|
2023
Q1 | $911 | Hold |
9
| – | – | ﹤0.01% | 1246 |
|
|
2022
Q4 | $1.08K | Hold |
9
| – | – | ﹤0.01% | 1222 |
|
|
2022
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 1166 |
|
|
2022
Q2 | $1K | Sell |
9
-100
| -92% | -$11.1K | ﹤0.01% | 1118 |
|
|
2022
Q1 | $10K | Buy |
109
+100
| +1,111% | +$9.17K | ﹤0.01% | 910 |
|
|
2021
Q4 | $1K | Buy |
+9
| New | +$1K | ﹤0.01% | 1046 |
|